DNA Methyltransferase (DNMT) Activity Assay Service

Q: Q1: What is the minimum amount of DNMT enzyme required for activity assays?

For recombinant DNMTs, we typically require 10-100 ng per assay point. For endogenous enzymes in cell lysates, 10-50 μg of total protein is sufficient. The exact amount depends on the specific DNMT abundance and activity levels in your samples.

Q: Q2: Can you distinguish between de novo and maintenance DNMT activities?

A: Yes, we use substrate-specific approaches and selective inhibitors to differentiate between DNMT1 (maintenance) and DNMT3A/3B (de novo) activities. Hemimethylated DNA substrates are particularly useful for distinguishing maintenance methylation.

Q: Q3: How do you handle DNMT enzymes that are difficult to express and purify?

A: We have optimized expression systems for full-length DNMTs, including mammalian and insect cell systems. For particularly challenging targets, we can implement co-expression strategies and specialized purification protocols to ensure proper folding and activity.

Q: Q4: What controls are included to ensure assay specificity?

A: Each assay includes enzyme-free controls, substrate-only controls, specific inhibitor controls, and positive controls with known active DNMTs. We also use methylation-sensitive restriction enzymes to confirm methylation specificity.

As the primary writers of DNA methylation marks, DNMTs play indispensable roles in epigenetic inheritance, cell fate determination, and disease-associated epigenetic reprogramming. CD BioSciences offers specialized DNMT activity assay services designed to directly measure methyl group transfer to defined DNA substrates, enabling precise functional evaluation of DNMT enzymes under controlled in vitro conditions.

Introdution to DNA Methyltransferase (DNMT)

DNA methyltransferases (DNMTs) catalyze the transfer of a methyl group to cytosine bases, primarily in CpG dinucleotides, forming 5-methylcytosine as a key epigenetic mark regulating gene expression without altering the DNA sequence. DNMT1 maintains existing methylation patterns during DNA replication, while DNMT3A and DNMT3B establish new methylation patterns crucial for development. Assessing DNMT activity is critical for directly quantifying enzymatic function and understanding the epigenetic status in diseases. For example, elevated DNMT activity is observed in tumors like acute leukemia, often normalizing upon remission, highlighting its potential as a prognostic indicator. Conversely, reduced activity is linked to conditions like systemic lupus erythematosus.

Domain structure of DNA methyltransferase family members.

Fig.1 Domain structure of DNMT family members. (Kim D J, et al., 2025)

Our Services

CD BioSciences offers comprehensive DNA methyltransferase (DNMT) activity assay services to characterize the enzymatic activities responsible for establishing and maintaining DNA methylation patterns. Our specialized platform enables accurate profiling of DNMT family enzymes, providing critical insights into epigenetic regulation mechanisms for basic research and therapeutic development. Our technical methodology is centered on precise quantification of methyl group transfer, employing complementary platforms to ensure data robustness across different research scenarios.

Core Detection Technologies

Methyl Group Incorporation Assays

This direct method uses 3H-labeled S-adenosylmethionine (SAM) as the methyl donor to quantify the transfer of radiolabeled methyl groups to DNA substrates. It remains the gold-standard for obtaining fundamental kinetic parameters (Km, Vmax) with high sensitivity and a wide linear dynamic range.

Antibody-Based Readouts

We utilize antibodies highly specific for 5-methylcytosine (5-mC) in quantitative formats like ELISA or dot blot. This approach provides a robust and accessible means to measure global methylation levels across many samples, ideal for inhibitor screening and cellular activity profiling.

Fluorescence-Based Methods

Our homogeneous fluorescence polarization (FP) or TR-FRET assays enable real-time, high-throughput kinetic analysis in 384-well plates. These methods eliminate separation steps, offer excellent Z'-factors for robust screening, and are perfect for rapid compound library evaluation and mechanistic studies.

Orthogonal Validation (Optional)

Critical findings are confirmed using a complementary secondary technique, such as mass spectrometry (LC-MS/MS) or methylation-sensitive digestion. This rigorous validation step, combined with controlled experiments using specific substrates and inhibitors, guarantees the specificity and reproducibility of your activity data.

Detection Scope

DNMT Enzyme Family Analysis

We precisely quantify the activity of core DNMT enzymes, including the maintenance methyltransferase DNMT1 and the de novo methyltransferases DNMT3A and DNMT3B—along with their splice variants and isoforms, enabling detailed functional characterization.

Methylation Type Specificity

Our assays distinguish between maintenance methylation, which preserves patterns during DNA replication, and de novo methylation, which establishes new epigenetic marks, providing insights into their distinct biological roles.

CpG Site-Specific Targeting

Focusing on CpG dinucleotide contexts, we measure methylation efficiency at specific genomic loci or synthetic sequences, reflecting the enzyme's natural substrate preference and sequence specificity.

Mutant Enzyme Functional Profiling

We compare the activity of wild-type DNMTs with disease-associated or engineered mutants, facilitating research into functional defects, structure-activity relationships, and the mechanistic basis of epigenetic dysregulation.

Cofactor & Regulator Investigations

The influence of essential cofactors (e.g., SAM, metal ions) and regulatory proteins (e.g., DNMT3L) on enzymatic kinetics and processivity can be assessed to uncover complex regulatory networks.

Samples and Applications

Supported Sample Types

Small molecules & Chemical Modulators: DNMT inhibitors (nucleoside/non-nucleoside), epigenetic modulators, natural product extracts, reference/control compounds, compound libraries for screening.
DNA & Nucleic Acid Substrates: Unmethylated plasmid DNA, hemimethylated DNA substrates, synthetic CpG-rich oligonucleotides, PCR-amplified genomic fragments, custom-designed sequence contexts.
Purified & Recombinant Enzymes: Full-length DNMT proteins (DNMT1/3A/3B), catalytic domain constructs, recombinant wild-type/mutant variants, enzymes from bacterial/insect/mammalian expression systems.
Synthetically Modified DNA Substrates: Pre-methylated DNA controls, oligonucleotides with defined methylation patterns, nucleosome-core particles, chromatinized templates.
Cellular & Nuclear Extracts: Nuclear extracts from cultured cells/tissues, whole-cell lysates, samples from specific disease models (upon feasibility assessment).

Diverse Application Scenarios

Enzyme Kinetic Characterization: Determines Michaelis-Menten kinetics for SAM and DNA substrates, and defines inhibition constants for candidate compounds.
Biological Sample Profiling: Measures endogenous DNMT activity in cell lysates, tissue extracts, and clinical samples for disease mechanism studies.
Drug Discovery Support: Enables high-throughput screening of compound libraries and detailed mechanistic studies of epigenetic drug candidates.
Substrate Specificity Analysis: Evaluates enzyme preference for different DNA sequences and methylation states (e.g., hemi-methylated vs. unmethylated DNA).

Service Workflow

Our streamlined, five-step workflow ensures rigorous experimental design, precise execution, and in-depth data interpretation, providing you with reliable, actionable results at every stage.

Initial Consultation & Customized Assay Design

We begin by discussing your specific research objectives, sample types (e.g., recombinant enzyme, cell lysates), and required data endpoints. Based on this, we design a tailored assay strategy, selecting the optimal detection method (e.g., radiometric, fluorescence) and substrate to meet your goals.

Method Development & Optimization

We systematically optimize all critical reaction parameters, including enzyme concentration, incubation time, SAM co-factor levels, and buffer conditions. This phase establishes a robust, linear, and reproducible assay system specific to your samples before full-scale testing.

Sample Preparation & Quality Control

Your samples are processed under controlled conditions. We perform essential quality controls, such as measuring protein concentration, assessing substrate integrity, and running positive/negative controls to ensure all components are suitable for accurate activity measurement.

Assay Execution & Multi-Platform Data Acquisition

Activity measurements are conducted using the agreed-upon platform(s). For key projects, we may employ a secondary method to cross-validate critical findings. All assays include full replicate sets and a comprehensive panel of controls to monitor specificity and background.

Comprehensive Data Analysis & Reporting

We process the raw data to calculate kinetic or inhibition parameters (e.g., velocity, IC50). Our final report provides not only the quantified results and statistical analysis but also a clear interpretation of the findings in the context of your research question.

Why Choose Us?

Unmatched Sensitivity in Detection: Our platform achieves detection limits as low as 0.1 ng of DNMT enzyme per reaction, enabling accurate activity measurement even in limited biological samples through optimized radiolabeled SAM incorporation assays.
Versatile Platform Adaptability: We support multiple detection methodologies including fluorescence-based high-throughput screening, mass spectrometry quantification, and radioisotopic assays, allowing customized approach selection based on specific research requirements and sample types.
Rigorous Quality Assurance: Every assay incorporates comprehensive controls including enzyme-negative samples, substrate-only reactions, and validated inhibitor controls, ensuring data reliability with inter-assay variability maintained below 15% CV.
Expert Data Interpretation: Our team provides detailed kinetic analysis including Km and Vmax determination, coupled with biological context interpretation based on extensive experience in cancer epigenetics and developmental biology applications.

Frequently Asked Questions (FAQs)

Q1: What is the minimum amount of DNMT enzyme required for activity assays?

Q2: Can you distinguish between de novo and maintenance DNMT activities?

Q3: How do you handle DNMT enzymes that are difficult to express and purify?

Q4: What controls are included to ensure assay specificity?

CD BioSciences' DNA Methyltransferase Activity Assay Service provides robust, quantitative data to advance your epigenetic research. Our combination of sophisticated detection technologies, rigorous quality control, and expert interpretation ensures reliable results for your most challenging investigations. Contact us today to discuss your specific requirements and develop a customized project plan.

Reference

1. Kim D J. The role of the DNA Methyltransferase family and the therapeutic potential of DNMT inhibitors in tumor treatment[J]. Current Oncology, 2025, 32(2): 88.